¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease : 2023-06-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease : 2023-06-10
±³À°ÀÏÀÚ : 2023-06-10
±³À°Àå¼Ò : µ¿°ü 6Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease

ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ±èÀº¿µ
¿¬¶ôó : 02-3010-3130  

À̸ÞÀÏ : plm3010@amc.seoul.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í 1.Àü¹®ÀÇ »çÀüÁ¢¼ö 50,000¿ø ÇöÀåÁ¢¼ö 60,000¿ø2. ÀüÀÓÀÇ, Àü°øÀÇ ¹× °£È£»ç, ±âŸ µî »çÀüÁ¢¼ö 40,000¿ø ÇöÀåÁ¢¼ö 50,000¿ø

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 09:00~09:25 Refractory chronic cough: Mechanisms and treatment updates ¼Û¿ìÁ¤(¼­¿ï¾Æ»êº´¿ø ¾Ë·¹¸£±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 09:25~09:50 The optimal treatment of MAC pulmonary disease Á¶°æ¿í(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 09:50~10:15 Beyond inhaler: non-pharmacologic treatment in COPD À̼¼¿ø(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

ÈÞ½Ä 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 10:15~10:30 COFFEE BREAK ()

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 10:30~10:40 Importance of accurate nodal staging in stage III NSCLC Áö¿øÁØ(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 10:40~11:05 Optimal strategy of surgical treatment in stage III NSCLC À±À籤(¼­¿ï¾Æ»êº´¿ø ½ÉÀåÇ÷°üÈäºÎ¿Ü°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 11:05~11:30 Update of perioperative chemotherapy in stage III NSCLC À±½Å±³(¼­¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 11:30~11:55 Current practice of radiation therapy in stage III NSCLC ½Å¿µ¼·(¼­¿ï¾Æ»êº´¿ø ¹æ»ç¼±Á¾¾çÇаú)

½Ä»ç 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 11:55~13:00 LUNCH ()

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 13:00~13:25 Updated IPF guideline and PPF (progressive pulmonary fibrosis : radiologic aspect äÀºÁø(¼­¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 13:25~13:50 Hopes and concerns about PAH targeted therapy in PH-ILD ÀÌÀç½Â(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 13:50~14:15 Lung transplantation in ILD patients ±èȣö(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

ÈÞ½Ä 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 14:15~14:30 COFFEE BREAK ()

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 14:30~14:55 Effect of corticosteroid therapy in severe pneumonia and ARDS ÇãÁø¿ø(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 14:55~15:20 Severe viral pneumonia other than COVID-19 ÃÖ»óÈ£(¼­¿ï¾Æ»êº´¿ø °¨¿°³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 15:20~15:45 Treatment of moderate to severe ARDS ¾ÈÁöȯ(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease : 2023-06-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼҾÆÀçÈ°¹ß´ÞÀÇÇÐȸ Çмú´ëȸ : 2023-06-10
´ÙÀ½±Û 2023³â ¼­¿ï¾Æ»êº´¿ø ³úÁ¹Áß ½ÉÆ÷Áö¾ö From Basic Principles to Advanced Techniques : 2023-06-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20853 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¤Çü¿Ü°ú Á¦21ȸ SMC Orthopedic Symposium 2024 : 2024-06-23 0 10 2024-05-27
20852 ÀÎõ Á¦3ȸ ÀÎÇϴ뺴¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò : 2024-06-22 0 18 2024-05-27
20851 °æ±â (¿Â¶óÀÎ) Á¦7ȸ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾îÁö·³Áõ¼¾ÅÍ ¿¬¼ö°­Á : 2024-06-22 0 31 2024-05-27
20850 ±¤ÁÖ 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22 0 17 2024-05-27
20849 ¼­¿ï ´ëÇÑÃé´ãµµÇÐȸ [¿Â¶óÀÎ] Pancreato-Biliary Summer School 2024 (PB-SS) : 2024-06-22 0 17 2024-05-27
20848 ¼­¿ï Á¦26Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : °áÇÙ°ú ºñ°áÇÙÇ×»ê±Õ ÆóÁúȯÀÇ ÃÖ½ÅÁö°ß : 2024-06-22 0 28 2024-05-27
20847 ¼­¿ï Á¦3ȸ Severance Orthopaedic Review(¼¼ºê¶õ½º ±Ù°ñ°Ý ¿¬¼ö°­ÁÂ) : 2024-06-22 0 11 2024-05-27
20846 ¼­¿ï (¿Â¶óÀÎ)2024³â ¼­´ë¹®±¸ÀÇ»çȸ ¿Â¶óÀÎÇмú´ëȸ : 2024-06-22 0 19 2024-05-27
20845 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 2ÀÏÂ÷ : 2024-06-22 0 22 2024-05-27
20844 ´ë±¸ 2024³â Á¦ 23ȸ ´ëÇѵΰ³¾È¸é¼ºÇü¿Ü°úÇÐȸ Ãá°è½ÉÆ÷Áö¾ö : 2024-06-22 0 13 2024-05-27
20843 ¼­¿ï µ¿ÀÛ±¸ÀÇ»çȸ ÀÇÇÐ ¿¬¼ö±³À°(¸¸¼ºÁúȯ, Å»¸ð¿Í ÇǺΰü¸®, »ý¼ºÇü AI Æ®·»µå¿Í ÀÇ·á, ÀÇ·áºÐÀï) : 2024-06-22 0 18 2024-05-27
20842 ¼­¿ï (¿Â¶óÀÎ) °øȲ¹üºÒ¾ÈÀå¾Ö Ä¡·áÀÇ ½ÉÃþÀû Á¢±Ù : 2024-06-22 0 12 2024-05-27
20841 °æ±â 2024³â ´ëÇѳëÀκñ´¢ÀÇÇÐȸ Á¦7Â÷ Á¤±âÇмú´ëȸ : 2024-06-22 0 13 2024-05-27
20840 ¼­¿ï (¿Â¶óÀÎ) Á¦34Â÷ ´ëÇѼҾÆÀÓ»ó¸é¿ªÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 22 2024-05-27
20839 ´ë±¸ 2024 ´ë±¸±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 31 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷